294 related articles for article (PubMed ID: 9440696)
1. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes.
Hemesath TJ; Price ER; Takemoto C; Badalian T; Fisher DE
Nature; 1998 Jan; 391(6664):298-301. PubMed ID: 9440696
[TBL] [Abstract][Full Text] [Related]
2. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi.
Wu M; Hemesath TJ; Takemoto CM; Horstmann MA; Wells AG; Price ER; Fisher DZ; Fisher DE
Genes Dev; 2000 Feb; 14(3):301-12. PubMed ID: 10673502
[TBL] [Abstract][Full Text] [Related]
3. Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia.
Price ER; Ding HF; Badalian T; Bhattacharya S; Takemoto C; Yao TP; Hemesath TJ; Fisher DE
J Biol Chem; 1998 Jul; 273(29):17983-6. PubMed ID: 9660747
[TBL] [Abstract][Full Text] [Related]
4. Microphthalmia: a signal responsive transcriptional regulator in development.
Fisher DE
Pigment Cell Res; 2000; 13 Suppl 8():145-9. PubMed ID: 11041373
[TBL] [Abstract][Full Text] [Related]
5. Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes.
Kim DS; Kim SY; Chung JH; Kim KH; Eun HC; Park KC
Cell Signal; 2002 Sep; 14(9):779-85. PubMed ID: 12034359
[TBL] [Abstract][Full Text] [Related]
6. STAT3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon serine 727.
Ng J; Cantrell D
J Biol Chem; 1997 Sep; 272(39):24542-9. PubMed ID: 9305919
[TBL] [Abstract][Full Text] [Related]
7. Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes.
Sonnenblick A; Levy C; Razin E
Mol Cell Biol; 2004 Dec; 24(24):10584-92. PubMed ID: 15572665
[TBL] [Abstract][Full Text] [Related]
8. C-KIT signaling depends on microphthalmia-associated transcription factor for effects on cell proliferation.
Phung B; Sun J; Schepsky A; Steingrimsson E; Rönnstrand L
PLoS One; 2011; 6(8):e24064. PubMed ID: 21887372
[TBL] [Abstract][Full Text] [Related]
9. A single UVB exposure increases the expression of functional KIT in human melanocytes by up-regulating MITF expression through the phosphorylation of p38/CREB.
Mizutani Y; Hayashi N; Kawashima M; Imokawa G
Arch Dermatol Res; 2010 May; 302(4):283-94. PubMed ID: 19937254
[TBL] [Abstract][Full Text] [Related]
10. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.
McGill GG; Horstmann M; Widlund HR; Du J; Motyckova G; Nishimura EK; Lin YL; Ramaswamy S; Avery W; Ding HF; Jordan SA; Jackson IJ; Korsmeyer SJ; Golub TR; Fisher DE
Cell; 2002 Jun; 109(6):707-18. PubMed ID: 12086670
[TBL] [Abstract][Full Text] [Related]
11. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.
Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Cherqui G; Perret C; Capeau J
Oncogene; 2001 Jan; 20(2):252-9. PubMed ID: 11313952
[TBL] [Abstract][Full Text] [Related]
12. Targeting the microphthalmia basic helix-loop-helix-leucine zipper transcription factor to a subset of E-box elements in vitro and in vivo.
Aksan I; Goding CR
Mol Cell Biol; 1998 Dec; 18(12):6930-8. PubMed ID: 9819381
[TBL] [Abstract][Full Text] [Related]
13. Microphthalmia associated transcription factor is a target of the phosphatidylinositol-3-kinase pathway.
Khaled M; Larribere L; Bille K; Ortonne JP; Ballotti R; Bertolotto C
J Invest Dermatol; 2003 Oct; 121(4):831-6. PubMed ID: 14632202
[TBL] [Abstract][Full Text] [Related]
14. Stem Cell Factor-Inducible MITF-M Expression in Therapeutics for Acquired Skin Hyperpigmentation.
Yun CY; Roh E; Kim SH; Han J; Lee J; Jung DE; Kim GH; Jung SH; Cho WJ; Han SB; Kim Y
Theranostics; 2020; 10(1):340-352. PubMed ID: 31903124
[No Abstract] [Full Text] [Related]
15. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells.
Seternes OM; Johansen B; Moens U
Mol Endocrinol; 1999 Jul; 13(7):1071-83. PubMed ID: 10406459
[TBL] [Abstract][Full Text] [Related]
16. Sphingosylphosphorylcholine is a Melanogenic Stimulator for Human Melanocytes.
Higuchi K; Kawashima M; Ichikawa Y; Imokawa G
Pigment Cell Res; 2003 Dec; 16(6):670-8. PubMed ID: 14629725
[TBL] [Abstract][Full Text] [Related]
17. The stem cell factor-stimulated melanogenesis in human melanocytes can be abrogated by interrupting the phosphorylation of MSK1: evidence for involvement of the p38/MSK1/CREB/MITF axis.
Niwano T; Terazawa S; Nakajima H; Imokawa G
Arch Dermatol Res; 2018 Apr; 310(3):187-196. PubMed ID: 29362867
[TBL] [Abstract][Full Text] [Related]
18. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
Tsatsanis C; Patriotis C; Tsichlis PN
Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
[TBL] [Abstract][Full Text] [Related]
19. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
[TBL] [Abstract][Full Text] [Related]
20. The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription.
Yavuzer U; Keenan E; Lowings P; Vachtenheim J; Currie G; Goding CR
Oncogene; 1995 Jan; 10(1):123-34. PubMed ID: 7824265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
